Tongce Medical controversies
Controversies tied to this brand in public sources. A listing is not a finding of fault.
Back to profile4 entries
2024
Warned over associate's overdue repayment of financial assistance and actual controller's failure to honor repayment undertaking
In May 2024, an ophthalmology associate of Tongce Medical failed to repay financial assistance funds as scheduled, and Lü Jianming failed to honor his undertaking to repay on its behalf, leading to a warning from the Zhejiang Securities Regulatory Bureau. The relevant company was also regulated for its duty in the matter, and the same fund repayment event is recorded together.
2022
Chairman enters scenic area to burn incense during pandemic closure, sparking controversy
In February 2022, Tongce Medical chairman Lü Jianming entered a scenic area that was not open to the public at the time to burn incense, prompting questions about pandemic control and privilege; the scenic area confirmed it was closed. The entry is a public allegation and is not written as a confirmed penalty for violating pandemic regulations.
2022
Ordered to rectify over undisclosed related-party fund dealings and insufficient independence
In August 2022, the Zhejiang Securities Regulatory Bureau found that Tongce Medical had failed to perform decision-making and disclosure procedures for 143.2 million yuan in non-operating fund dealings with enterprises controlled by the actual controller, along with issues concerning independence, and ordered the company and its responsible persons to rectify the problems.
2021
Chairman clashes with netizens on Xueqiu, sparking listed-company communication controversy
In October 2021, Tongce Medical chairman Lü Jianming replied to netizens on Xueqiu, saying that shareholders of the company were a disgrace to it, which sparked controversy. The company responded that it was an exchange of views and that different people had different opinions.